Education Center

A First-Line Treatment Option for Adults with Spasticity or Cervical Dystonia

This content is sponsored by Ipsen Biopharmaceuticals, Inc.

 

Click Here to Read Content.

This supplement to Federal Practitioner highlights the safety and efficacy profile of a treatment option for adults with spasticity or cervical dystonia (CD). Topics include:

Upper and Lower Limb Spasticity (ULS and LLS):

  • Mean change in Modified Ashworth Scale scores in the primary target muscle group
  • Physician's Global Assessment of response to treatment
  • Duration of response to treatment in patients with ULS or LLS

Cervical Dystonia:

  • Findings from 2 studies in treatment-naïve CD patients
  • Improvement in head position as measured by reduction in Toronto Western Spasmodic Torticollis Rating Scale
  • Duration of response to treatment and time to retreatment

Click Here to Read Content.

Next Article: